RR\ID (Rapid Reviews\Infectious Diseases) is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints.
Latest preprint reviews
-
Estimated COVID-19 Cases and Hospitalizations Averted by Case Investigation and Contact Tracing in the US
This article has 13 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021
This article has 29 authors:Reviewed by Rapid Reviews Infectious Diseases, NCRC, ScreenIT
-
Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
This article has 24 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Comprehensive antibody profiling of mRNA vaccination in children
This article has 18 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant
This article has 16 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
MITIGATING THE 4 th WAVE OF THE COVID-19 PANDEMIC IN ONTARIO
This article has 3 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Can a vaccine-led approach end the NSW outbreak in 100 days, or at least substantially reduce morbidity and mortality?
This article has 8 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx Community
This article has 18 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 wildtype, alpha, and delta variant dominance in the UK: prospective cohort study
This article has 11 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April–May 2022
This article has 10 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT